|
[1]Dahari H, Shudo E, Ribeiro RM, et al.Modeling complexdecay profiles of hepatitis B virus during antiviral therapy[J].Hepatology, 2009, 49 (1) :32-38.
|
|
[2]Lewin SR, Ribeiro RM, Walters T, et al.Analysis of hepati-tis B viral load decline under potent therapy:complex decayprofiles observed[J].Hepatology, 2001, 34 (5) :1012-1020.
|
|
[3]Nowak MA, Bonhoeffer S, Hill AM, et al.Viral dynamics inhepatitis B virus infection[J].Proc Natl Acad Sci U S A, 1996, 93 (9) :4398-4402.
|
|
[4]Eigen M.Molecular self-organization and the early stagesof evolution[J].Experientia, 1971, 27 (11) :149-212.
|
|
[5]Domingo E.Quasispecies:concepts and implications for vi-rology[J].Virology, 2006, 299:17-20.
|
|
[6]Blum HE.Hepatitis B virus:significance of naturally occur-ring mutants[J].Intervirology, 1993, 35 (1-4) :40-50.
|
|
[7]Ngui SL, Teo CG.Hepatitis B virus genomic heterogeneity:variation between quasispecies may confound molecular epi-demiological analyses of transmission incidents[J].J ViralHepat, 1997, 4 (5) :309-315.
|
|
[8]董菁, 成军, 王勤环, 等.乙型肝炎病毒X基因准种与变异特点的研究[J].肝脏, 2001, 6 (S1) :70.
|
|
[9]董菁, 成军, 王勤环, 等.乙型肝炎病毒反转录酶区基因序列准种与变异特点[J].病毒学报, 2001, 17 (3) :270-272.
|
|
[10]董菁, 成军, 王勤环, 等.乙型肝炎病毒C基因启动子区准种与变异特点的研究[J].肝脏, 2001, 6 (S1) :73.
|
|
[11]董菁, 成军, 王勤环, 等.慢性乙型肝炎患者体内乙型肝炎病毒准种特点的初步研究[J].中华传染病杂志, 2001, 19 (4) :199-203.
|
|
[12]中华医学会.慢性乙型肝炎防治指南[J].中华传染病杂志, 2005, 23 (6) :421-431.
|
|
[13]de la Torre JC, Holland JJ.RNA virus quasispecies popula-tions can suppress vastly superior mutant progeny[J].J Vir-ol, 1990, 64 (12) :6278-6281.
|
|
[14]Domingo E, Gomez J.Quasispecies and its impact on viralhepatitis[J].Virus Res, 2007, 127 (2) :131-150.
|
|
[15]Zhang X, Liu C, Gong Q, et al.Evolution of wild type andmutants of the YMDD motif of hepatitis B virus polymeraseduring lamivudine therapy[J].J Gastroenterol Hepatol, 2003, 18 (12) :1353-1357.
|
|
[16]Wang F, Wang H, Shen H, et al.Evolution of hepatitis B vi-rus polymerase mutations in a patient with HBeAg-positivechronic hepatitis B virus treated with sequential monotherapyand add-on nucleoside/nucleotide analogues[J].Clin T-her, 2009, 31 (2) :360-366.
|
|
[17]Locarnini S.Hepatitis B viral resistance:mechanisms and di-agnosis[J].J Hepatol, 2003, 39 (Suppl 1) :S124-132.
|
|
[18]秦艳丽, 张继明, 黄玉仙, 等.阿德福韦治疗拉米夫定耐药慢性乙型肝炎患者的耐药率及耐药株进化情况[J].中华肝脏病杂志, 2007, 15 (1) :4-7.
|
|
[19]Yim HJ, Hussain M, Liu Y, et al.Evolution of multi-drugresistant hepatitis B virus during sequential therapy[J].Hep-atology, 2006, 44 (3) :703-712.
|
|
[20]黄燕萍, 王宇明, 兰林, 等.应用单链构象多态性和异源双链分析研究拉米夫定耐药变异[J].中华检验医学杂志, 2004, 27 (8) :490-492.
|
|
[21]Chen L, Zhang Q, Yu DM, et al.Early changes of hepatitisB virus quasispecies during lamivudine treatment and the cor-relation with antiviral efficacy[J].J Hepatol, 2009, 50 (5) :895-905.
|
|
[22]Liu F, Chen L, Yu DM, et al.Evolution Patterns of HepatitisB Virus Quasispecies under Different Selective Pressures:Correlation with Antiviral Efficacy[J].Gut, 2011, 60 (9) :1269-1277.
|
|
[23]Lim SG, Cheng Y, Guindon S, et al.Viral Quasi-Species E-volution During Hepatitis Be Antigen Seroconversion[J].Gastroenterology, 2007, 133 (3) :951-958.
|
|
[24]Wu S, Imazeki F, Kurbanov F, et al.Evolution of hepatitis Bgenotype C viral quasi-species during hepatitis B e antigenseroconversion[J].J Hepatol, 2011, 54 (1) , 19-25.
|
|
[25]Baldick CJ, Eggers BJ, Fang J, et al.Hepatitis B virus qua-sispecies susceptibility to entecavir confirms the relationshipbetween genotypic resistance and patient virologic response[J].J Hepatol, 2008, 48 (6) :895-902.
|
|
[26]Petropoulos CJ, Parkin NT, Limoli KL, et al.A novel pheno-typic drug susceptibility assay for human immunodeficiencyvirus type 1[J].Antimicrob Agents Chemother, 2000, 44 (4) :920-928.
|
|
[27]Morozova O, Marra MA.Applications of next-generationsequencing technologies in functional genomics[J].Ge-nomics, 2008, 92 (5) :255-264.
|
DownLoad: